IGF1 and Hepatic steatosis: The principal findings include the followings: (1) During CCl4-induced hepatic steatosis and fibrosis, hepatocyte premature senescence initiated by oxidative stress; whereas IGF-1 gene therapy suppressed these effects to improve hepatic steatosis and fibrogenesis.